CVS Health Corporation

Symbol: CVS.DE

XETRA

51.26

EUR

Market price today

  • 9.5099

    P/E Ratio

  • 0.6685

    PEG Ratio

  • 64.35B

    MRK Cap

  • 0.05%

    DIV Yield

CVS Health Corporation (CVS-DE) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.15%

Operating Profit Margin

0.03%

Net Profit Margin

0.02%

Return on Assets

0.03%

Return on Equity

0.10%

Return on Capital Employed

0.08%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Healthcare Plans
CEO:Ms. Karen Sue Lynch
Full-time employees:219000
City:Woonsocket
Address:One CVS Drive
IPO:2007-10-24
CIK:

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.

General Outlook

When we look at how much money they make before expenses, they keep 0.149% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.035%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.020%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.029% return, is a testament to CVS Health Corporation's adeptness in optimizing resource deployment. CVS Health Corporation's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.098%. Furthermore, the proficiency of CVS Health Corporation in capital utilization is underscored by a remarkable 0.076% return on capital employed.

Stock Prices

CVS Health Corporation's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $69.08, while its low point bottomed out at $67.52. This variance in figures offers investors a lucid insight into the roller-coaster ride that is CVS Health Corporation's stock market.

Liquidity Ratios

Analyzing CVS.DE liquidity ratios reveals its financial health of the firm. The current ratio of 80.98% gauges short-term asset coverage for liabilities. The quick ratio (54.38%) assesses immediate liquidity, while the cash ratio (11.76%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio80.98%
Quick Ratio54.38%
Cash Ratio11.76%

Profitability Ratios

CVS.DE profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 2.74% underscores its earnings before tax deductions. The effective tax rate stands at 25.56%, revealing its tax efficiency. The net income per EBT, 74.14%, and the EBT per EBIT, 78.56%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 3.48%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin2.74%
Effective Tax Rate25.56%
Net Income per EBT74.14%
EBT per EBIT78.56%
EBIT per Revenue3.48%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 0.81, it details the span from stock purchase to revenue. The 1 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding54
Days of Inventory Outstanding19
Operating Cycle51.99
Days of Payables Outstanding16
Cash Conversion Cycle36
Receivables Turnover11.20
Payables Turnover22.40
Inventory Turnover18.80
Fixed Asset Turnover12.00
Asset Turnover1.45

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 8.64, and free cash flow per share, 6.46, depict cash generation on a per-share basis. The cash per share value, 10.39, showcases liquidity position. A payout ratio of 0.44 highlights the portion of earnings distributed as dividends. Lastly, the operating cash flow sales ratio, 0.03, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share8.64
Free Cash Flow per Share6.46
Cash per Share10.39
Payout Ratio0.44
Operating Cash Flow Sales Ratio0.03
Free Cash Flow to Operating Cash Flow Ratio0.75
Cash Flow Coverage Ratio0.13
Short Term Coverage Ratio1.30
Capital Expenditure Coverage Ratio3.96
Dividend Paid and Capex Coverage Ratio1.83
Dividend Payout Ratio0.03

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 32.75%, highlights its total liabilities relative to assets. With a debt-equity ratio of 1.11, we discern the balance between debt and equity financing. The long-term debt to capitalization, 49.82%, and total debt to capitalization, 52.51%, ratios shed light on its capital structure. An interest coverage of 4.51 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio32.75%
Debt Equity Ratio1.11
Long Term Debt to Capitalization49.82%
Total Debt to Capitalization52.51%
Interest Coverage4.51
Cash Flow to Debt Ratio0.13
Company Equity Multiplier3.38

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 278.42, provides a glimpse into top-line earnings distributed across each share. Net income per share, 6.49, reflects the portion of profit attributed to each share. The book value per share, 59.50, represents the net asset value distributed per share, while the tangible book value per share, -34.14, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share278.42
Net Income Per Share6.49
Book Value Per Share59.50
Tangible Book Value Per Share-34.14
Shareholders Equity Per Share59.50
Interest Debt Per Share63.85
Capex Per Share-2.36

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 10.95%, indicates top-line expansion, while the gross profit growth, 0.25%, reveals profitability trends. EBIT growth, -15.43%, and operating income growth, -15.43%, offer insights into operational profitability progression. The net income growth, 93.55%, showcases bottom-line expansion, and the EPS growth, 106.69%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth10.95%
Gross Profit Growth0.25%
EBIT Growth-15.43%
Operating Income Growth-15.43%
Net Income Growth93.55%
EPS Growth106.69%
EPS Diluted Growth106.05%
Weighted Average Shares Growth-2.06%
Weighted Average Shares Diluted Growth-2.49%
Dividends per Share Growth10.00%
Operating Cash Flow Growth-17.01%
Free Cash Flow Growth-22.71%
10-Year Revenue Growth per Share167.31%
5-Year Revenue Growth per Share49.39%
3-Year Revenue Growth per Share35.63%
10-Year Operating CF Growth per Share119.88%
5-Year Operating CF Growth per Share23.05%
3-Year Operating CF Growth per Share-13.79%
10-Year Net Income Growth per Share72.09%
5-Year Net Income Growth per Share1241.26%
3-Year Net Income Growth per Share18.40%
10-Year Shareholders Equity Growth per Share90.88%
5-Year Shareholders Equity Growth per Share6.69%
3-Year Shareholders Equity Growth per Share12.25%
10-Year Dividend per Share Growth per Share170.40%
5-Year Dividend per Share Growth per Share24.86%
3-Year Dividend per Share Growth per Share21.59%
Receivables Growth29.15%
Inventory Growth-5.58%
Asset Growth9.40%
Book Value per Share Growth9.93%
Debt Growth12.23%
SGA Expenses Growth3.07%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 173,017,827,840, captures the company's total value, considering both debt and equity. Income quality, 1.60, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 48.25%, indicates the value of non-physical assets, and capex to operating cash flow, -22.58%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value173,017,827,840
Income Quality1.60
Sales General and Administrative to Revenue0.11
Intangibles to Total Assets48.25%
Capex to Operating Cash Flow-22.58%
Capex to Revenue-0.85%
Capex to Depreciation-69.42%
Stock-Based Compensation to Revenue0.16%
Graham Number93.24
Return on Tangible Assets6.46%
Graham Net Net-98.21
Working Capital-11,331,000,000
Tangible Asset Value-43,870,000,000
Net Current Asset Value-105,234,000,000
Invested Capital1
Average Receivables31,251,500,000
Average Payables14,867,500,000
Average Inventory18,557,500,000
Days Sales Outstanding36
Days Payables Outstanding18
Days of Inventory On Hand22
ROIC6.60%
ROE0.11%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 0.94, and the price to book ratio, 0.94, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.19, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 8.52, and price to operating cash flows, 6.39, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio0.94
Price to Book Ratio0.94
Price to Sales Ratio0.19
Price Cash Flow Ratio6.39
Price Earnings to Growth Ratio0.67
Enterprise Value Multiple-0.15
Price Fair Value0.94
Price to Operating Cash Flow Ratio6.39
Price to Free Cash Flows Ratio8.52
Price to Tangible Book Ratio1.33
Enterprise Value to Sales0.48
Enterprise Value Over EBITDA9.08
EV to Operating Cash Flow12.89
Earnings Yield8.19%
Free Cash Flow Yield10.21%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of CVS Health Corporation (CVS.DE) on the XETRA in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 9.510 in 2024.

What is the ticker symbol of CVS Health Corporation stock?

The ticker symbol of CVS Health Corporation stock is CVS.DE.

What is company IPO date?

IPO date of CVS Health Corporation is 2007-10-24.

What is company current share price?

Current share price is 51.260 EUR.

What is stock market cap today?

The market cap of stock today is 64350266200.000.

What is PEG ratio in 2024?

The current 0.668 is 0.668 in 2024.

What is the number of employees in 2024?

In 2024 the company has 219000.